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The peripheral blood monocyte (PBM) migrates into tissues and 
differentiates into mature tissue macrophages. Previous investi- 
gations from our laboratory have demonstrated that PBM have re- 
duced 5-lipoxygenase (5-LO) metabolism of arachidonic acid 
(AA) and 5-LO activating protein (FLAP) expression as compared to 
differentiated alveolar macrophages (AM). Moreover, PBM differentiated 
with 1,25_dihydroxyvitamin D3 (1,25-(OH),D,) displayed increased 
leukotriene synthesis and a parallel increase in FLAP expression. In the 
present study, we sought to examine the physiological role of 1,25- 
(OH),D,? in the regulation of eicosanoid metabolism in termi- 
nally differentiated alveolar and peritoneal macrophages (PM), uti- 
lizing a well characterized rat model of vitamin D,-deficiency, 
AM from vitamin D,-deficient rats demonstrated reduced 5-LO me- 
tabolism of AA and a parallel reduction in FLAP expression 
compared to control rats. Similarly, PM from vitamin D,-deficient 
rats demonstrated reduced 5-LO metabolism ofAA. The effect of vitamin 
D, was specific for the 5-LO pathway, not affecting total release of 
AA or its metabolism via 12-lipoxygenase or cyclooxoygenase 
Address correspondence to: Michael J. Coffey M.D., Division of Pulmonary and 
Critical Care Medicine, 3916 Taubman Center, 1500 E Medical Center Drive, 
Ann Arbor MI 48 109-0360. 
*Recipient of a Clinical Investigator Development Award from the National 
Heart, Lung, and Blood Institute. 
¶Recipient of a Career Investigator Award from the American Lung Association. 
0 1994 Butterworth-Heinemann Prostaglandins 1994:48, November 313 
Eicosanoid metabolism in vitamin D,-deficient rats: Coffey et al. 
(COX) pathways in macrophages. Furthermore, it did not affect COX 
protein expression in macrophages or type II alveolar epithelial 
cells. In control animals, 1,25-(OH)2D3 concentrations were greater 
in bronchoalveolar lavage fluid (2.6fold) and peritoneal lavage 
fluid (1.6-fold) than in serum, which may account for the greater 
FLAP expression in AM and PM than in PBM. These observations suggest 
that 1,25-(OH),D, plays a physiological role in upregulating the 5- 
LO pathway in tissue macrophages in vivo. 
Keywords: Eicosanoids; leukotrienes; prostaglandins; vitamin D,; alveolar; 
peritoneal 
Introduction 
Macrophages provide first line protection against exogenous toxins and 
invading microorganisms. All tissue macrophages arise by emigration 
from the bloodstream and subsequent differentiation of a bone marrow- 
derived precursor, the peripheral blood monocyte (PBM). Differentiation 
of various cell types is promoted by 1,25dihydroxyvitamin D, (1,25- 
(OH),D,). 4~21 In particular, 1,25-(OH),D, has been shown to differentiate 
PBM to a more mature macrophage phenotype, as judged by the expression 
of maturation-associated antigens, and release of tumor necrosis factor 
and interleukin-6.16 
The ability of macrophages to play an important role in host defense 
mechanisms is related, in part, to their capacity to generate various media- 
tors, which include eicosanoids. Leukotrienes (LTs) are potent mediators 
of inflammation derived from the 5lipoxygenase (5-LO) pathway of ara- 
chidonic acid (AA) metabolism which have been implicated in a wide 
range of immune and inflammatory diseases, including asthma, rheuma- 
toid arthritis, inflammatory bowel disease and psoriasis.‘Ql8 In most rest- 
ing cells, the enzyme 5-LO resides predominantly in the soluble 
subcellular fraction.15,27 Upon cell activation, 5-LO interacts with 5-LO 
activating protein (FLAP), a particulate protein22 which has been shown 
to be necessary for LT synthesis .8 Ordinarily, PBM metabolize AA to 
only small amounts of LTs, favoring metabolism via the prostaglandin 
H synthase or cyclooxygenase (COX) pathway to prostaglandins (PCs) 
instead.1 We have recently shown that this lesser ability to synthesize 
LTs is due primarily to their reduced expression of FLAP compared to 
AM.’ Interestingly, incubation of PBM with the differentiating agent 1,25- 
(OH),D, resulted in parallel increases in 5-LO metabolism of endogenous 
AA as well as in FLAP expression.5 
In view of the capacity of 1,25-(OH),D, to upregulate LT synthesis in 
vitro, we wished to determine whether 1,25-(OH),D, plays a physiological 
role in the regulation of the 5-LO pathway in macrophages in vivo. This 
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question was addressed by utilizing a well-characterized rat model of 
vitamin D,-deficiency. We hypothesized that macrophages from vitamin 
D,-deficient rats (D-) would demonstrate reduced 5LO metabolism of AA 
and FLAP expression as compared to normal rats (D + ). Both 5-LO and 
COX pathways, along with the expression of 5-LO, FLAP and COX pro- 
teins, were therefore compared in two terminally differentiated macro- 
phage populations, AM and peritoneal macrophages (PM]. For purposes 
of comparison, a non-macrophage cell, the type II alveolar epithelial cell 
(AEC) which lines the pulmonary alveolar space, was studied. This cell 
metabolizes AA largely via the COX pathway lacking appreciable levels 
of 5-LO or FLAP proteins. 
Materials and Methods 
D- and D+ rats 
Animal studies were performed after approval from the Unit for Labora- 
tory Animal Medicine at the University of Michigan. Sprague-Dawley 
rats specially bred from D - mothers (Harlan, Madison, WI) were housed 
in pathogen-free conditions under non-fluorescent lighting. The rats were 
rendered D- by feeding for 9 weeks with a vitamin D,-free diet which 
was supplemented with 2.5% Ca2+ and 1.5 % PO, (Teklad, Madison, WI, 
lot # 86029) to maintain serum Ca 2+ levels within normal limits, as 
described.32 D+ rats were obtained from the same source and housed 
under identical conditions, but the above diet was supplemented daily 
with 2 IU vitamin D3.“2 A separate group of normal pathogen-free Sprague- 
Dawley rats was used to determine the 1,25-(OH),D, levels in alveolar 
and peritoneal lining fluid. These animals were of the same strain, sex, 
size, and housed under identical pathogen-free conditions as the D + and 
D - animals. 
Isolation and Culture of AM and PM 
Paired animals from D - and D + groups were studied in parallel. Rat 
AM and PM were harvested by bronchoalveolar lavage (BAL) and perito- 
neal lavage, respectively, as described.6 Lavage buffer consisted of 150 
mM NaCl, 2.7 mM EDTA, 20 mM HEPES, 5.5 mM dextrose, 100 units/ 
ml penicillin, 100 Kg/ml streptomycin, and 0.25 mg/ml amphotericin B. 
Lavaged cells (BAL > 94% and peritoneal lavage > 8 1% macrophages) were 
either studied fresh or were adhered (> 98% macrophages) and cultured 
in medium 199 (M199) as described.26 
Isolation and Culture of Rat vpe II AEC 
Type II AEC were isolated by a standard technique.” Cells were suspended 
in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO, Grand Island, 
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NY) containing 10% fetal calf serum (FCS) with 100 units/ml penicillin, 
100 kg/ml streptomycin, and 0.25 mg/ml amphotericin B at 1.5 x lo6 
cells/ml and 2 mls of cell suspension added to 35 mm culture dishes 
(Falcon). Cells were cultured in a humidified atmosphere of 5% CO, in 
air at 37°C. The day of isolation and plating was designated culture day 
0. By day 2, cells form a confluent monolayer of which -94% are epithelial 
cells as judged by cytokeratin staining.19 
1,25-(OH),D,3 Assay 
Serum and lavage fluid samples were assayed for 1,25-(OH),D, using the 
1,25-(OH),D 3H Radio Receptor Assay Kit (INCSTAR Corporation, Still- 
water, MN) as described.‘” Briefly, the assay involves a preliminary extrac- 
tion and subsequent purification of vitamin D metabolites from serum or 
fluid using a C,, cartridge. Quantitation is achieved via a non-equilibrium 
competitive protein binding assay using a 1,25-(OH)2D 3H tracer and a 
thymus receptor that is specific for 1,25-(OH),D. Dextran-coated charcoal 
is then incubated with the sample-receptor cocktail, binds to the unbound 
hormone, and is pelleted by centrifugation. The supernatant, which con- 
tains the thymus receptor-bound hormone, is decanted into a scintillation 
vial and counted. Values are corrected for extraction efficiency using a 
recovery factor and final concentration of 1,25-(OH),D, in the sample is 
expressed as pg/ml. 
Analysis of AA metabolism in Intact Cells 
Cell lipids were prelabeled by incubation with 1 &i [3H]AA (sp. act 
60-100 Ci/mmol; DuPont-New England Nuclear, Boston MA) in Ml99 
containing 10% FCS during overnight culture. Cells were washed and 
the maximal capacity for eicosanoid synthesis was determined by incuba- 
tion in Ml99 for 30 min with ionophore A23 187 (Calbiochem, La Jolla, 
CA), diluted to a final concentration of 1 PM in DMSO (final concentration 
0.5%). Medium from cultures was extracted using CR Sep-Paks (Waters, 
Milford, CA), and eicosanoids were separated by reverse-phase HPLC, 
identified by co-elution with authentic staniArds, and quantitated by 
scintillation counting of fractions.’ In selected experiments 5-LO meta- 
bolic capacity of unlabeled A23187stimulated cells was estimated by 
enzyme immunoassay (EIA) (Cayman, Ann Arbor, MI) of the cellular 
supernatants for LTB,, the major 5-LO product of rat AM and PM.2”. 
Cell Lysis and Subcellular Fractionation 
Fresh or cultured cells were suspended in homogenization buffer (50 mM 
potassium phosphate, 100 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol, 
0.5 mM PMSF, and 60 pg/ml soybean trypsin inhibitor, pH 7.1). They 
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were disrupted by sonication on iced ethanol using a model 250 Sonifier 
(Branson Ultrasonics Corp., Danbury, CT) at power level 1 and 20% duty 
cycle for 1.5 min, achieving > 98% lysis. Lysates then underwent centrifu- 
gation at 100,000 x g for 60 min to obtain “soluble” (supernatant) and 
“particulate” (pellet) fractions. The particulate fraction was then rinsed 
twice and resuspended in homogenization buffer by sonication (power 
level 1, 100% duty cycle, 10 s). Total protein content of subcellular frac- 
tions was determined using a microtiter plate modification of the Bradford 
method (Pierce, Rockford IL) with BSA as standard. 
Immunoblot Analysis of Total Cellular 5-LO, FLAP, and COX 
Proteins 
Steady-state protein levels of 5LO, FLAP, and the two isoforms of COX, 
COX-1 and COX-2, were determined by immunoblot analysis using a 
modification of methods described previously.6 Briefly, equal amounts of 
protein (5-20 pg) were separated by SDS-PAGE on 10% (5-LO, COX-1 
and COX-2) and 15% (FLAP) gels, by the method of Laemm1i.l’ High and 
low molecular weight rainbow markers (Amersham, Arlington, IL) were 
also loaded on each gel. After overnight transfer to nitrocellulose mem- 
branes (Bio-rad Laboratories, Richmond, CA), blots were blocked by incu- 
bating for 1 h with 10% non-fat dried milk in Tris buffered saline (TBS), 
washed in TBS containing 0.1% Tween 20 (TBS-T), and incubated at 
room temperature for 1 h with rabbit polyclonal primary antibodies raised 
against the following: human leukocyte 5-LO (1:3000 dilution); amino 
acid residues 41-52 of the human FLAP sequence (1:5000 dilution) (both 
kindly provided by Dr. J. Evans, Merck Frosst, Dorval, Canada); sheep 
seminal vesicle COX-1 (1:5000 dilution) (both kindly provided by Dr. W. 
Smith, Michigan State University, E. Lansing, MI), and a 17-amino acid 
peptide derived from the murine COX-2 sequence not present in COX- 
1 (1:300 dilution) (kindly provided by Dr. D. Dewitt, Michigan State 
University). After washing, blots were incubated for 1 h with horseradish 
peroxidase-conjugated goat anti-rabbit IgG (Amersham) at a dilution of 
1:5000 (5-LO, FLAP and COX-2), or 1: 10,000 (COX-1) in TBS-T. Mem- 
branes were then washed and developed using the ECL chemiluminescent 
western blotting system (Amersham). Luminescent bands were quanti- 
tated by video densitometry using software from Scion Corp (Frederick, 
MD). 
Data Analysis 
Where indicated, data were expressed as the mean + SEM. Statistical 
analysis was performed using a Student’s t test. A p value < 0.05 was 
considered significant. 
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Results 
Body Weight, Cell Count, and 1,25-(OH),D, Levels 
Pairs of D + and D - rats were sacrificed at 9 to 12 weeks and studied in 
parallel. Body weight of D- rats (398.8 + 74.5 g) was significantly less 
than that of D+ rats (501.2 + 79.7 g) (p < 0.05, n =9 pairs), but they 
exhibited no mortality or apparent morbidity. There were no differences 
in the numbers of macrophages obtained by lavage from D+ (AM, 13.7 
+- 9.2 x 106per animal; PM, 27.3 ? 10.7 x 106) and D- rats (AM, 15.8 
k 10.5 x 106; PM, 17.7 + 6.7 x 106) (p=s, n=9 pairs). As expected,32 
1,25-(OH) D 1 2 3 evels in serum from D - rats (1.8 pg / ml or 0.5 x lo4 pg / 
kg of protein) were markedly less than from D+ rats (33.9 pg / ml or 9 
x lo4 pg / p,g of protein). 1,25-(OH),D, levels in BAL and peritoneal lavage 
fluids were measured from pooled samples obtained from a separate group 
of 4 normal control Sprague-Dawley rats, and in vivo vitamin D, concen- 
trations calculated by correcting for estimated volumes of alveolar lining 
fluid30 and peritoneal lining f1uid.j The calculated 1,25-( OH),D, concentra- 
tions in BAL fluid in normal control rats was 88 pg / ml (2.6-fold that of 
serum) and peritoneal lavage fluid was 56 pg / ml (1.6-fold that of serum]. 
Reduced 5-LO Metabolism of AA in AM and PM from Vitamin D, 
Deficient Rats 
Having previously shown that in vitro exposure of PBM to the differentiat- 
ing agent 1,25-(OH),D, upregulated LT synthetic capacity and FLAP ex- 
pression, we were interested in determining whether 1,25-(OH),D, might 
have a physiological role in regulating these processes during macrophage 
differentiation in vivo. This was addressed by studying mature resident 
AM and PM obtained from D + and D - rats. Following A23 187 stimula- 
tion, D + AM elaborated free AA, 12-(S)-hydroxy-6,8,11,14-eicosatetra- 
enoic acid (12-HETE), and the 5-LO products LTB, and 5-(S)-hydroxy- 
6,8,11,14-eicosatetraenoic acid (5-HETE), and small amounts of COX 
products (PGE,, thromboxane [TX] B,, and HHT [ 12_hydroxyheptadecatri- 
enoic acid] were also seen, as expectedz6 (Figure 1A). Stimulated AM from 
D - animals released similar amounts of total radioactivity as did those 
from D+ animals (data not shown). Amounts of 12-HETE and of COX 
products were also similar in cells from D- animals, but they released 
65% less LTB, and 67% less 5-HETE than did AM from D+ animals 
(Figure 1A). An increase in unmetabolized AA in AM from D- animals 
(82% of total radiolabel) as compared to D + AM (68%) suggests a reduced 
ability to metabolize the available endogenous AA. The reduction in 
5-LO metabolism of AA in AM from D- animals was confirmed by 
immunoassay of LTB, (Figure 1B) (n = 4 pairs, p ~0.05). 
PM were examined in similar fashion. HPLC analysis of A23187- 
stimulated products elaborated by prelabeled PM from D + rats indicated 
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FIGURE 1. Eicosanoid synthesis in AM from D+ and D- rats. (A) AM from D+ and D- rats 
were adhered for 1 h in Ml 99 and lipids labeled during overnight incubation with PH]AA. Cells 
were stimulated with A23187 (1 ~.LM) for 30 min and radiolabeled eicosanoids separated by 
HPLC analysis, as described in the “Materials and Methods.” For each metabolite or group of 
metabolites, data for D + (solid bars) and D - (checked bars) are expressed as the percent of 
total 3H-labeled products eluted. “COX products” include TxB,, PGE,, and HHT. “5-LO products” 
include LTB, and 5-HETE. (B) Unlabeled AM from D+ and D- rats were adhered for 1 h in 
M199, washed and stimulated with A23187. Medium was then harvested for quantitation of 
immunoreactive LTB,. Data for cells from D - (checked bars) rats are expressed as a percentage 
of the paired D+ (solid bars) value (28.13 t 12.29 nglml) and represent the mean + S.E.M. 
from 4 pairs of rats; *p < 0.05. 
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a predominance of COX metabolites, including PGE,, TxB,, 6-keto PGF,,, 
and HHT, over 5LO products 5-HETE and LTB,, as previously reported.26 
Small amounts of 12-HETE were also synthesized. Stimulated PM from 
D - animals released similar amounts of total radioactivity as did those 
from D+ animals (data not shown). PM from D- animals generated 
similar quantities of COX and 12-LO products, but 35% less 5-LO prod- 
ucts, than did PM from D+ rats (Figure 2A). Likewise, the reduction in 
5-LO metabolic capacity of AA in PM from D - animals was confirmed 
by EIA of LTB, (Figure 2B) (n =4 pairs, p co.05 J. 
Reduced FLAP Expression in AM from Vitamin D, deficient Rats 
AM from D + and D - rats were compared for 5-LO and FLAP expression. 
Figure 3 presents representative autoradiographs, as well as mean densito- 
metric analysis of such data from 4 pairs of rats. Lysates of fresh AM from 
both groups of rats contained 5-LO protein in both soluble and particulate 
fractions, as we have reported previously for normal resting rat AM.6 
There was no difference in the subcellular distribution of 5-LO between 
D + and D - AM. Both subcellular fractions were thus analyzed by densi- 
tometry and combined to give the mean quantitative data. There was no 
difference in 5-LO expression in AM from D + and D - rats (Figure 3A). 
FLAP, by contrast, was only detected in the particulate fraction. Notably, 
cells from D- rats exhibited a 52 ? 14.6% reduction in FLAP protein 
compared to D+ AM (Fig. 3B) (p< 0.05) 
In selected experiments, AM from D - rats were incubated overnight 
with 50 nM exogenous 1,25-(OH),D,. The addition of exogenous 1,25- 
(OH),D, restored LTB, synthetic capacity towards the level observed in 
D + cells (Figure 4B), and caused a corresponding increase in FLAP expres- 
sion (Figure 4A). These data strongly suggest that the defects in 5-LO 
metabolism of AA and FLAP expression in D - AM were indeed related 
to 1,25-( OH),D, deficiency. 
Likewise, the expression of 5-LO and FLAP was determined in PM 
from D + and D - rats. As previously reported,6 D + PM demonstrated a 
trend towards lower levels of 5-LO protein expression than D+ AM (5- 
LO expression in PM as a % of AM: 62.2 + 44.6%, n =3, p = s). FLAP 
expression was also comparable in the two cell types (FLAP expression 
in PM as a % of D + AM: 156.8 + 86.2%, n =3, p = s), as previously 
demonstrated.5 There was no significant difference in the subcellular 
distribution of 5-LO in PM from D - rats compared to D + rats (data not 
shown). There was no reduction (71% of D + ) in 5-LO expression in AM 
from D - rats (data not shown). Similarly, cells from D - rats exhibited 
no reduction (97.1 + 14.2% of D +) in FLAP protein compared to D+ 
PM. 





















FIGURE 2. Eicosanoid synthesis in PM from D + and D - rats. (A) PM from D + and D - rats 
were adhered for 1 h, labeled overnight with [3H]AA, and stimulated with A23187. Quantitation 
of individual metabolites or groups of metabolites for D + (solid bars) and D - (checked bars) 
are expressed as described in the legend to Figure 1. “COX products” include TxB,, PGE,, 6- 
keto PGF,, and HHT. “5-LO products” include LTB, and 5-HETE. (B) Unlabeled PM from D+ 
and D - rats were adhered, stimulated with 1 ~.LM A231 87 for 30 min and the media harvested 
for quantitation of immunoreactive LTB,. Data for cells from D - rats are expressed as a percent- 
age of the paired D+ value (3.53 t 2.7 ng/ml) and represent the mean + S.E.M. from 4 pairs 
of rats; *p < 0.05. 
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FIGURE 3. 5-LO and FLAP expression in AM from D + and D - rats. Equal amounts of soluble 
(s) and particulate (p) proteins (5-20 pg) obtained from AM of D + and D - rats were subjected 
to immunoblot analysis of 5-LO (A) and FLAP (8) as described in the ‘Materials and Methods.” 
Upper panels show representative autoradiographs from a single pair of rats. Lower panels 
demonstrate relative levels of 5LO (soluble plus particulate fractions) (A) and FLAP (particulate 
fraction only) (B) in cells from both groups of animals as anlayzed by video densitometry. Levels 
in cells from D- rats are expressed as a percentage of the paired D+ value and represent 
the mean + S.E.M. from 4 pairs of rats; l p < 0.05. 
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FIGURE 4. Effect of exogenous vitamin D, on FLAP expression and LTB, synthesis in AM from 
D - rats. AM from D + and D - rats were adhered in Ml99 for 1 h, washed and then cultured 
overnight in Ml 99 containing 10% FCS with or without 1,25-(OH),D, (50 nM). (A) Autoradiograph 
depicting immunoblot analysis of FLAP. (B) A23187induced (1 FM for 30 min) LTB, synthetic 
capacity under the same conditions. In this experiment AM from D + rats (3.9 ng/ml) synthesized 
greater amounts of LTB, than AM from D- rats (1.7 ng/ml), and this was almost completely 
restored (3.5 ng/ml) by overnight incubation with 1,25-(OH),D,. 
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COX Protein Expression in Macrophages and Type II AEC is Similar 
in D+ and D- Rats 
As indicated above, there was no significant difference in COX metabo- 
lism of AA in AM or PM from D - as compared to D + rats. To extend 
this finding, expression of COX proteins was determined in AM and PM 
from D+ and D - rats. COX-2 was not detected in fresh AM or PM, 
which is consistent with its inducible role,” but COX-1 was expressed 
in resting cells. Confirming the metabolic data, there was no reduction 
in COX-1 protein expression in either macrophage cell type obtained from 
D- rats (AM, 114.7 2 27.6% of D+; PM, 92.8 t 18.5% of D+, n=5). 
Figure 5A demonstrates a representative immunoblot analysis of COX-1 
and COX-2 proteins in AM from D + and D - rats. Type II AEC line the 
alveolar surface, and have a high capacity for prostaglandin synthesis.‘9 
Therefore, expression of COX proteins was examined in type II AEC 
isolated from D + and D - rats and harvested after 48 h in culture. These 
cells expressed both COX- 1 and COX-2 proteins. There was no reduction 
in COX-1 or -2 expression in cells from D - animals (126% and 118% of 
D f, respectively, n=2) (Figure 5B). 5-LO and FLAP expression were not 
detected (data not shown). 
Discussion 
We have previously demonstrated that PBM exhibit reduced FLAP expres- 
sion compared to differentiated macrophages,’ and that 1,25-(OH),D,- 
differentiated PBM exhibit a parallel increase in 5-LO metabolism of AA 
and FLAP expression.s An increase in LT synthetic capacity in HL-60 cells 
incubated with 1,25-(OH),D, has also been reported.4 Consequently, the 
present study was performed to evaluate the physiological role of 1,25- 
(OH),D, in regulating eicosanoid metabolism in mononuclear phagocytes. 
For comparison, type II AEC were studied. We examined both 5-LO and 
COX pathways in addition to the expression of 5-LO, FLAP, COX-1, and 
COX-2 proteins. Several important findings emerged from this study. 1) 
AM from D- rats demonstrated parallel reduction in 5-LO metabolism 
of AA and FLAP (but not of 5LO) expression compared to AM from D + 
rats. 2) 5-LO metabolism of AA was also reduced in PM from D- rats, 
albeit without any significant change in FLAP expression. 3) The physio- 
logical role of vitamin D, appears to be specific for the 5-LO pathway, 
since its deficiency did not affect overall AA release in macrophages, the 
COX metabolic pathway or COX protein expression in either macrophages 
or type II AEC, or the 12-LO pathway in macrophages. 4) 1,25-(OH),D, 
concentrations in BAL and peritoneal lavage fluids exceeded that in serum, 
which may help explain the relatively greater FLAP expression in mature 
AM and PM than in precursor PBM. 
A unique feature of this study was our ability to address a possible in 
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FIGURE 5. COX protein expression in AM and type II AEC from D + and D - rats. (A) Particulate 
proteins (7 pg) obtained from AM from D + and D - rats were subjected to immunoblot analysis 
for COX-1, as described in the “Materials andMethods.” Particulate fractions (20 kg) obtained 
from type II AEC from D+ and D- rats were subjected to immunoblot analysis for both 
COX-1 and COX-2, as described in the “Materials and Methods. ” 
vivo role for 1,25-(OH),D, in regulating eicosanoid metabolism in macro- 
phages by making use of an established rat model of vitamin D, deficiency. 
Determination of 1,25-(OH),D, levels in the serum verified the deficiency 
state of the experimental model. Interestingly, 1,25-(OH),D, levels in 
normal rats were 2.6-fold higher in BAL fluid and 1.6-fold higher 
in peritoneal lavage fluid than in serum. Greater 1,25-(OH),D, levels in 
these compartments than in serum might account for the greatly increased 
FLAP expression in AM and PM compared to PBM.5 The mechanism 
underlying the greater 1,25-(OH),D, levels in BAL and peritoneal lavage 
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fluid than in serum is unknown. Notably, resident AM from D - animals 
demonstrated a selective decrease in LT synthetic capacity which was 
associated with a significant decrease in FLAP expression, as compared 
to cells from matched D+ rats. The magnitude of reduction in 5LO 
metabolism of AA and in FLAP expression were quantitatively similar 
( i.e., -50% of D + levels]. That these defects were indeed a consequence 
of 1,25-(OH),D, deficiency was confirmed by showing that they were 
largely corrected by the addition of exogenous 1,25-(OH)zD3. 
As compared to cells from normal rats, PM from D- rats exhibited a 
reduction in 5-LO metabolism of AA which was of similar magnitude to 
that observed in AM. However, this was not associated with a significant 
reduction in FLAP expression. These data in PM do not conform neatly 
to the hypothesis that FLAP expression is a function of 1,25-(OH),D, 
levels. An alternative explanation for this finding in PM includes the 
possible effect of vitamin D, deficiency on other factors, apart from FLAP 
or 5-LO expression, which might regulate the 5-LO pathway. 1,25-(OH),D, 
is known to augment intracellular Ca 2+ levels23 and the transcription24 
as well as activation of protein kinase C.29,31 Reduction in any of these 
effects might be expected to decrease the level of 5-LO metabolism of 
AA within the cell since LT synthetic capacity is dependent on intracellu- 
lar Ca2+ concentration@ and levels of active protein kinase C.25 
The effect of 1,25-(OH)2D3 appears to be specific for the 5-LO pathway, 
as vitamin D, deficiency did not affect the total quantity of AA release 
or the metabolism of AA via the 12-LO or COX pathways in macrophages. 
The lack of effect on the COX pathway was confirmed by immunoblot 
analysis for COX-1, the constitutively expressed COX isoform, in AM 
and PM. COX-2 was not detected in fresh AM or PM. In type II AEC, 
which express COX-1 and COX-2, neither COX isoform was reduced in 
D - as compared to D + animals. This is in keeping with our previous data 
with 1,25-(OH),D,-differentiated PBM, in which there was no significant 
effect on PC synthesis.5 By contrast, it has been previously reported that 
1,25-(OH),D, increased COX metabolism of AA in HL-60 cells.14 These 
results, which differed from those presented here, might be explained by 
differences in the cell type studied (malignant HL-60 cell line) or in culture 
conditions (lower 1,25-( OH),D, concentration, and serum-free Isocove’s 
modified Dulbecco’s medium]. 
In summary, our data strongly indicate that 1,25-(OH),D, is not merely 
capable of upregulating 5-LO metabolism of AA by increasing FLAP ex- 
pression, as previously reported,5 but that 1,25-(OH),D, plays a physiologi- 
cal role in maintaining FLAP expression and the 5-LO pathway in mature 
AM in vivo. Considering the role of 5-LO products, especially LTB,, as 
chemotactic factors important in normal host defense,20 this finding pro- 
vides a possible explanation for the increased susceptibility to infection 
which has been recognized in association with 1,25-(OH),D, deficiency.2,‘2 
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